the sales seem on the low side? although with those margins and profit you'd expect some major broker upgrades. i read the tolhurst research report just done in oct and they were forcasting 7.8 for 2007 yet GAA has already made 5.2 in 3 months.
i guess it all comes down to guidence given at the agm but if the 5.2 is repeated for the rest of the year giving 20 mill NPAT then $2 bucks here we come.
any comments appreciated
- Forums
- ASX - By Stock
- genepharm announces first quarter of profit
GAA
genepharm australasia limited
the sales seem on the low side? although with those margins and...
Featured News
Add GAA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online